Review of ticket searches determined there was normal complaint activity for lot 07003fn00.No other complaints were identified.Complaint trending reports for the architect afp assay was reviewed and determined that there were no trends associated with the complaint issue.Worldwide field data was used to assess the performance of the reagent lot.The median patient result for lot 07003fn00 was within the established baselines and comparable with all other lots in the field, confirming no systemic issue for the lot.Review of the product quality history for the lot did not identify any issues associated with the customers observation.Additionally, labelling was reviewed which adequately addresses the issue.No systemic issue or deficiency of the architect afp assay was identified.
|